APJULI Trademark

Trademark Overview

On Wednesday, December 17, 2014, a trademark application was filed for APJULI with the United States Patent and Trademark Office. The USPTO has given the APJULI trademark a serial number of 86483277. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 29, 2022. This trademark is owned by AstraZeneca AB. The APJULI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology
apjuli

General Information

Serial Number86483277
Word MarkAPJULI
Filing DateWednesday, December 17, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 29, 2022
Registration Number4887953
Registration DateTuesday, January 19, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 9, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Friday, July 29, 2022CANCELLED SEC. 8 (6-YR)
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 19, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 19, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, October 22, 20151(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, October 5, 2015NOTICE OF ALLOWANCE CANCELLED
Thursday, October 22, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 5, 2015TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, August 4, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 9, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 9, 2015PUBLISHED FOR OPPOSITION
Wednesday, May 20, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 1, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, April 25, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 23, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 23, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 20, 2015ASSIGNED TO LIE
Thursday, April 16, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 27, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 27, 2015NON-FINAL ACTION E-MAILED
Friday, March 27, 2015NON-FINAL ACTION WRITTEN
Friday, March 27, 2015ASSIGNED TO EXAMINER
Saturday, December 20, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 20, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

apjuli oncology substances preparations pharmaceutical